TOPICYCLINE
LOE ApproachingNDATOPICALFOR SOLUTION
Approved
Sep 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 27m ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOPICYCLINE is a topical tetracycline-class antibiotic solution approved in 1977 for dermatological infections. The exact indication and mechanism of action are not publicly detailed in available data, but topical tetracyclines are typically used for bacterial skin infections and acne. This is a legacy small-molecule product with a well-established safety profile.
LOE Approaching
Product is in advanced stage of patent life erosion with limited commercial expansion opportunities; team focus is on maintaining market position and managing generic transition.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TOPICYCLINE offers limited growth trajectory but provides stability in a mature, legacy product. Career value lies in defensive strategy execution, cost optimization, and transition management rather than expansion or innovation.
Brand ManagerProduct Manager
Worked on TOPICYCLINE at Takeda? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.